Insiders · UPB

UPB insider transactions

Upstream Bio Inc. (UPB) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for UPB

• 78d
  CFO and COO Gray Michael sold $7,915 worth of shares (852 units at $9.29), decreasing direct ownership by 3% to 29,648 units (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 78d
  Chief Medical Officer Deykin Aaron sold $8,305 worth of shares (894 units at $9.29), decreasing direct ownership by 3% to 32,687 units (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 78d
  Chief Executive Officer Sutherland Everett Rand sold $19,444 worth of shares (2,093 units at $9.29), decreasing direct ownership by 3% to 72,907 units (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 78d
  General Counsel Ambrose Allison sold $4,413 worth of shares (475 units at $9.29), decreasing direct ownership by 3% to 16,525 units (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 78d
  Chief Business Officer Houghton Adam sold $6,494 worth of shares (699 units at $9.29), decreasing direct ownership by 3% to 24,301 units (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 148d
  Chief Business Officer Houghton Adam was granted 25,000 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 148d
  Chief Medical Officer Deykin Aaron was granted 32,000 shares, increasing direct ownership by 2,024% to 33,581 units (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 148d
  General Counsel Ambrose Allison was granted 17,000 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 148d
  CFO and COO Gray Michael was granted 30,500 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 148d
  Chief Executive Officer Sutherland Everett Rand was granted 75,000 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 356d
  SEC Form 4 filed by Director Renaud Ronald C Jr

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 356d
  SEC Form 4 filed by Director Ruddy Marcella K.

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 356d
  SEC Form 4 filed by Director Chimovits Erez

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 356d
  SEC Form 4 filed by Director Fleming Harold Edward

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 356d
  SEC Form 4 filed by Director Beckman Daniella

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 356d
  SEC Form 4 filed by Director Ratcliffe Liam

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 481d
  SEC Form 4 filed by Chief Executive Officer Sutherland Everett Rand

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 481d
  SEC Form 4 filed by CFO and COO Gray Michael

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 481d
  SEC Form 4 filed by Chief Business Officer Houghton Adam

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 481d
  SEC Form 4 filed by Chief Medical Officer Deykin Aaron

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 481d
  SEC Form 4 filed by General Counsel Ambrose Allison

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 533d
  SEC Form 4 filed by General Counsel Ambrose Allison

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 533d
  SEC Form 3 filed by new insider Ambrose Allison

  3 - Upstream Bio, Inc. (0002022626) (Issuer)
• 594d
  Director Chimovits Erez bought $14,025,000 worth of shares (825,000 units at $17.00) and converted options into 3,609,789 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 594d
  Director Orbimed Advisors Llc bought $14,025,000 worth of shares (825,000 units at $17.00) and converted options into 3,609,789 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 594d
  Large owner Ai Upstream Llc bought $19,975,000 worth of shares (1,175,000 units at $17.00) and converted options into 4,319,410 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  Large owner Wellington Biomedical Innovation Master Investors (Cayman) Ii L.P. converted options into 894,733 shares (SEC Form 4)

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  SEC Form 4 filed by Director Renaud Ronald C Jr

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  SEC Form 4 filed by Director Ratcliffe Liam

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  SEC Form 4 filed by Director Ruddy Marcella K.

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  SEC Form 4 filed by Director Beckman Daniella

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  SEC Form 4 filed by Director Fleming Harold Edward

  4 - Upstream Bio, Inc. (0002022626) (Issuer)
• 596d
  SEC Form 4 filed by Director Chimovits Erez

  4 - Upstream Bio, Inc. (0002022626) (Issuer)